![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
GSK and CureVac to develop next generation mRNA COVID-19 vaccines
GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19...
Drug Research
Abzena selected to develop and manufacture antibody cocktail for Immunome’s COVID-19 Antibody Based Treatment
Immunome, Inc., a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, and Abzena, a partner...
Drug Research
Humanetics receives US DoD funding for Covid-19 drug development
Humanetics has received funding from the US Department of Defense (DoD) to carry out a series of studies with its novel drug candidate, BIO...
Drug Research
X-Chem Acquires IntelliSyn and Sister Company, AviSyn, to Extend and Streamline Drug Discovery Service Range
X-Chem, Inc. (X-Chem), the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn, a Montreal-based drug discovery services company and its US-based...
Drug Research
BioMed X Institute starts new research project in drug delivery in collaboration with Janssen
German independent research institute BioMed X announces its new research project with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of...
Drug Research
Enara and Boehringer Ingelheim sign oncology partnership
Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against overlooked dark antigen targets. How could dark antigens improve...
Drug Research
Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Germany
Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read